AIP

ANALYST NOTE: ARTERIS, INC. (AIP) DATE: 2026-06-13 SUBJECT: Structural Setup Analysis & Business Thesis

1. Structural Readiness

Conservative Entry: $20.17 Current Price: $44.11 Extension: +118.7% vs. conservative entry Breakout Level: $20.17 (Conservative Entry)

Analysis:

2. The Thesis Layer

Primary Secular Thesis: AI Infrastructure → Semiconductors & Foundry (Tier Second-Order, Moderate Confidence).

Thesis Context: Arteris operates as a critical enabler within the AI Infrastructure theme, specifically addressing the "Semiconductors & Foundry" sub-sector. The company's role is that of a beneficiary of the increasing complexity in AI chip design. As AI workloads migrate from data centers to edge devices and physical AI systems, the demand for advanced on-chip data movement and security has surged.

Directness of Exposure: Management explicitly stated as of May 12, 2026, that "2-thirds of our customer engagements are into AI chips." This direct exposure to the AI design cycle positions Arteris not merely as a passive observer but as a structural component in the supply chain for sophisticated AI SoCs (System-on-Chips). The thesis is further reinforced by the company's acquisition of Cycuity, which addresses the growing industry concern regarding data security in chiplets—a critical requirement for high-value AI and enterprise computing hardware.

3. The Business

Business Model & Industry: Arteris, Inc. specializes in the development, licensing, and support of advanced on-chip interconnect fabric technology (Network-on-Chip or NoC) and IP deployment solutions. The company operates in the Technology sector, providing intellectual property (IP) that facilitates data movement within complex System-on-Chip (SoC) designs. The business model relies on a mix of upfront license fees and recurring royalties based on production volume.

Supporting Evidence (As of 2026-06-13):

• Revenue & Contract Value: In the first quarter of 2026 (ended March 31), Arteris reported Annual Contract Value (ACV) plus royalties of $92.8 million, a 39% year-over-year increase and a new record high. The Remaining Performance Obligations (RPO), representing future contract revenue, totaled $118 million, up 33% year-over-year.
• Design Starts: The company reported 25 Confirmed Design Starts in the three months ended March 31, 2026, indicating strong pipeline activity.
• Guidance: Management expects to report a non-GAAP operating profit as early as the fourth quarter of 2026. For the full year 2026, guidance for ACV plus royalties is $102 million to $106 million, and revenue is guided to $91 million to $95 million (a 32% year-over-year increase at the midpoint).
• Geographic & Sector Mix: 58.5% of revenue in Q1 2026 came from outside the United States, with 23.8% from China. The customer base spans enterprise computing, automotive, communications, consumer electronics, and aerospace and defense.
• Acquisition Impact: On January 14, 2026, Arteris completed the acquisition of Cycuity for approximately $43.1 million, strengthening its portfolio in data movement security for chiplets.

4. Archetype and Conviction

Archetype: Margin Inflector.

Rationale: The company fits the Margin Inflector archetype. Management has explicitly guided that the company expects to achieve non-GAAP operating profit by Q4 2026. This transition from a net loss position (Q1 2026 net loss was $8.0 million) to profitability, driven by the scaling of high-margin IP licensing and the leverage of the RPO backlog, is the defining characteristic of this archetype. The "Margin Inflector" status is supported by the record-high ACV and the expectation that the fixed costs of R&D and sales will be amortized over a growing revenue base.

Conviction Stack:

• Thesis Strength: Moderate. The AI Infrastructure theme is robust, and Arteris is a direct beneficiary of the "second-order" effects of AI chip complexity (data movement and security).
• Evidence Quality: High. The evidence base is dense with specific, quantitative data points from Q1 2026 earnings and SEC filings, including record RPO, specific design start counts, and clear guidance updates.
• Structural Quality: High. The setup is confirmed with a wide stop ($13.69) relative to the entry, providing a large margin of safety against volatility. The ATR at breakout (5.4%) was in the "high" sweet spot, and the current ATR (6.4%) remains in the "very high" range, indicating active market participation.
• Rerating Potential: Significant. The market is currently pricing in a growth story with a path to profitability. The transition to non-GAAP profitability in Q4 2026 could serve as a catalyst for multiple expansion, particularly given the "Margin Inflector" narrative.

5. Invalidations, Strengtheners, and Gaps

Invalidation Triggers:

• Fundamental Deterioration: A significant miss in Q2 2026 guidance, particularly a reduction in the RPO backlog or a delay in the path to non-GAAP profitability beyond Q4 2026, would weaken the Margin Inflector thesis.
• Design Start Decline: A sharp drop in Confirmed Design Starts below the Q1 2026 level of 25 would signal a slowdown in the pipeline.

Strengtheners:

• Profitability Milestone: Confirmation of non-GAAP operating profit in Q4 2026 as guided.
• RPO Growth: Continued growth in Remaining Performance Obligations beyond the $118 million Q1 2026 level.
• New Sector Wins: Announcements of new license deals in high-growth sectors like enterprise computing or aerospace, as mentioned in recent guidance.

Evidence Gaps:

• Cash Flow Sustainability: While operating cash flow was positive in 2025 ($6.7 million), the Q1 2026 net loss of $8.0 million raises questions about the immediate cash burn rate relative to the acquisition of Cycuity. The specific cash flow trajectory for the remainder of 2026 is not yet detailed in the provided evidence.
• Customer Concentration: While the company lists diverse sectors, the specific revenue contribution of the top customers or the impact of the 23.8% China exposure on future revenue stability is not quantified in the provided snippets.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Record high ACV plus royalties of $92.8 million in Q1 2026; 25 Confirmed Design Starts in Q1 2026; Management guidance for non-GAAP operating profit by Q4 2026; 2/3 of customer engagements tied to AI chips. Key risks: High volatility (ATR 6.4%) increasing drawdown risk; Net loss of $8.0 million in Q1 2026 with path to profitability dependent on execution; Potential cash burn from Cycuity acquisition integration; Geographic revenue concentration in China. Sizing hint: Reduce position size relative to standard allocation due to very high ATR and extended price levels (+118%). Expected path: Price consolidates or trends higher as RPO converts to revenue and the company approaches the Q4 2026 profitability milestone. Expected horizon: 6 to 12 months to realize the margin inflection thesis.